Thomas Wilkinson

Angel investor in Salt Lake City

Invests in AI

Thomas Wilkinson's investor profile lists AI alongside Healthcare & Biotech, at seed. The record holds 3 deals, among them Eradivir, CareSpace: Virtual Therapy Platform and Monovo.

Email Investor

Email Investor

Credits to line up before a seed round

Thomas Wilkinson backs companies at seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Eradivir
  • CareSpace: Virtual Therapy Platform
  • Monovo

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech
Rounds
Seed
Profile
Angel investor
Deals on record
3
Based in
Salt Lake City, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Thomas Wilkinson invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Thomas Wilkinson's investor profile, together with Healthcare & Biotech. The stages on record are seed.
Which companies has Thomas Wilkinson backed?
The record lists 3 deals, including Eradivir, CareSpace: Virtual Therapy Platform and Monovo. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Thomas Wilkinson?
For a company raising a seed round, AI Perks lists credits such as Deepgram (up to $100,000), AssemblyAI (up to $150,000), MongoDB (up to $25,000) and AWS (up to $300,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor